pump prior to 30th june, page-24

I don't even think we need a miracle. Short term we need luck. Long term they are doing the right things just slower than we'd hoped. Two products on shelf will substantially lift revenue but only marginally increase costs due to synergies. Then add in the RED sunburn cream and suddenly you have 3products.

How many asx listed pharma have three products and a robust pipeline? And when we actually are cashflow positive we will be on a very small list.